BRIEF-Teva announces pricing of additional CHF1.0 billion of senior notes

* Teva announces pricing of additional CHF1.0 billion of senior notes in connection with pending acquisition of actavis generics
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.